Bivalirudin versus unfractionated heparin in acute coronary syndromes: an updated meta-analysis of randomized trials
M Verdoia, A Schaffer, L Barbieri… - Revista Española de …, 2016 - Elsevier
Introduction and objectives Contrasting data have been reported on bivalirudin as an
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - Revista Espanola de …, 2016 - research.uniupo.it
Introduction and objectives Contrasting data have been reported on bivalirudin as an
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
[引用][C] Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - REVISTA ESPAÑOLA …, 2016 - iris.uniupo.it
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis
of Randomized Trials IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …
of Randomized Trials IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - REVISTA ESPAÑOLA …, 2016 - iris.unime.it
Introduction and objectives: Contrasting data have been reported on bivalirudin as an
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials.
M Verdoia, A Schaffer, L Barbieri… - Revista Espanola de …, 2016 - europepmc.org
Methods Literature archives and main scientific sessions were scanned. The primary
efficacy endpoint was 30-day overall mortality. Secondary endpoints were stent thrombosis …
efficacy endpoint was 30-day overall mortality. Secondary endpoints were stent thrombosis …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - Revista Espa ola de …, 2016 - infona.pl
Contrasting data have been reported on bivalirudin as an anticoagulation strategy during
percutaneous coronary interventions, offering theoretical benefits on bleeding complications …
percutaneous coronary interventions, offering theoretical benefits on bleeding complications …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - Revista espanola …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction and objectives Contrasting data have been reported on bivalirudin as an
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
M Verdoia, A Schaffer, L Barbieri… - Revista Espanola de …, 2016 - research.uniupo.it
Introduction and objectives Contrasting data have been reported on bivalirudin as an
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …
anticoagulation strategy during percutaneous coronary interventions, offering theoretical …